Use of Antiplatelet Agents Is Inversely Associated With Liver Fibrosis in Patients With Cardiovascular Disease

Platelets participate in the development of liver fibrosis in animal models, but little is known about the benefit of antiplatelet agents in preventing liver fibrosis in humans. We therefore explored the relationship between the use of antiplatelet agents and liver fibrosis in a prospective cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarzkopf, Katharina, Bojunga, Joerg, Rüschenbaum, Sabrina, Martinez, Yolanda, Mücke, Marcus M., Seeger, Florian, Schoelzel, Fabian, Zeuzem, Stefan, Friedrich‐Rust, Mireen, Lange, Christian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287477/
https://www.ncbi.nlm.nih.gov/pubmed/30556044
http://dx.doi.org/10.1002/hep4.1254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287477/
https://www.ncbi.nlm.nih.gov/pubmed/30556044
http://dx.doi.org/10.1002/hep4.1254

Ejemplares similares